These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 12667430)
41. Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy. Nikol S; Huehns TY J Invasive Cardiol; 2001 Apr; 13(4):333-8. PubMed ID: 11287726 [TBL] [Abstract][Full Text] [Related]
42. Direct gene transfer for the understanding and treatment of human disease. Plautz GE; Nabel EG; Fox B; Yang ZY; Jaffe M; Gordon D; Chang A; Nabel GJ Ann N Y Acad Sci; 1994 May; 716():144-53. PubMed ID: 8024191 [TBL] [Abstract][Full Text] [Related]
43. Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation. Zhu NL; Wu L; Liu PX; Gordon EM; Anderson WF; Starnes VA; Hall FL Circulation; 1997 Jul; 96(2):628-35. PubMed ID: 9244236 [TBL] [Abstract][Full Text] [Related]
44. Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter. Huehns TY; Krausz E; Mrochen S; Schmid M; Engelmann MG; Esin S; Schrittenloher PK; Höfling B; Günzburg WH; Nikol S Atherosclerosis; 1999 May; 144(1):135-50. PubMed ID: 10381287 [TBL] [Abstract][Full Text] [Related]
45. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys. Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211 [TBL] [Abstract][Full Text] [Related]
46. iNOS gene transfer for graft disease. Barbato JE; Tzeng E Trends Cardiovasc Med; 2004 Oct; 14(7):267-72. PubMed ID: 15542378 [TBL] [Abstract][Full Text] [Related]
47. Gene transfer to arteries. Akyürek LM; San H; Nabel EG; Singh R; Simari RD Curr Protoc Hum Genet; 2002 Feb; Chapter 13():Unit13.1. PubMed ID: 18428325 [TBL] [Abstract][Full Text] [Related]
48. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101 [TBL] [Abstract][Full Text] [Related]
50. In vivo gene transfer of inducible nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits. Zanetti M; d'Uscio LV; Kovesdi I; Katusic ZS; O'Brien T Stroke; 2003 May; 34(5):1293-8. PubMed ID: 12690222 [TBL] [Abstract][Full Text] [Related]
51. Role of terminal and anastomotic circulation in the patency of arteries jailed by flow-diverting stents: animal flow model evaluation and preliminary results. Iosif C; Berg P; Ponsonnard S; Carles P; Saleme S; Pedrolo-Silveira E; Mendes G; Waihrich E; Trolliard G; Couquet CY; Yardin C; Mounayer C J Neurosurg; 2016 Oct; 125(4):898-908. PubMed ID: 26771853 [TBL] [Abstract][Full Text] [Related]
52. Vascular complications and gene therapy. Roy S; Rothschild JG; Chen A Expert Opin Biol Ther; 2003 Feb; 3(1):71-83. PubMed ID: 12718732 [TBL] [Abstract][Full Text] [Related]
53. Gene therapy for restenosis: current status. Rutanen J; Markkanen J; Ylä-Herttuala S Drugs; 2002; 62(11):1575-85. PubMed ID: 12109921 [TBL] [Abstract][Full Text] [Related]
54. Efficient transgene expression from naked DNA delivered into an arterio-venous fistula model for kidney dialysis. Globerman AS; Chaouat M; Shlomai Z; Galun E; Zeira E; Zamir G J Gene Med; 2011 Nov; 13(11):611-21. PubMed ID: 22002501 [TBL] [Abstract][Full Text] [Related]
55. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure. Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670 [TBL] [Abstract][Full Text] [Related]
56. [Local drug delivery and gene therapy]. Darius H; Buerke M; Boissel JP; Grosser T; Veit K; Zacharowski K; Meyer J Herz; 1997 Dec; 22(6):347-54. PubMed ID: 9483440 [TBL] [Abstract][Full Text] [Related]
57. Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Maillard L; Van Belle E; Smith RC; Le Roux A; Denéfle P; Steg G; Barry JJ; Branellec D; Isner JM; Walsh K Cardiovasc Res; 1997 Sep; 35(3):536-46. PubMed ID: 9415299 [TBL] [Abstract][Full Text] [Related]
58. Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. Muhs A; Heublein B; Schletter J; Herrmann A; Rüdiger M; Sturm M; Grust A; Malms J; Schrader J; von der Leyen HE Hum Gene Ther; 2003 Mar; 14(4):375-83. PubMed ID: 12659678 [TBL] [Abstract][Full Text] [Related]
59. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Janssens S; Flaherty D; Nong Z; Varenne O; van Pelt N; Haustermans C; Zoldhelyi P; Gerard R; Collen D Circulation; 1998 Apr; 97(13):1274-81. PubMed ID: 9570198 [TBL] [Abstract][Full Text] [Related]